Liver involvement in children with SARS-COV-2 infection: Two distinct clinical phenotypes caused by the same virus

Adriana Perez1, Amanda Cantor2, Bryan Rudolph1

  • 1Division of Gastroenterology, Hepatology and Nutrition, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY, USA.

Insights

Elevated liver enzymes (E-ALT) in children with SARS-CoV-2 infection indicate more severe disease, particularly in multisystem inflammatory syndrome (MIS-C). E-ALT was more common in MIS-C than COVID-19 but not linked to mortality.

Area of Science:

  • Pediatric Hepatology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection can cause acute liver injury (ALI), associated with poor outcomes in adults.
  • Understanding SARS-CoV-2 related liver injury in children is crucial for managing different disease manifestations.

Purpose of the Study:

  • To compare the characteristics of children with elevated alanine aminotransferase (E-ALT) in two SARS-CoV-2 manifestations: multisystem inflammatory syndrome in children (MIS-C) and COVID-19.
  • To identify factors associated with E-ALT in pediatric COVID-19 and MIS-C cases.

Main Methods:

  • Retrospective study of 291 patients ≤21 years old with SARS-CoV-2 PCR positivity.
  • E-ALT defined as ALT > 40 U/L. Bivariate and multivariable logistic regression analyses were performed.
  • Comparison of E-ALT prevalence and associated factors between COVID-19 and MIS-C cohorts.

Main Results:

  • 36% of patients had E-ALT (31% with COVID-19, 51% with MIS-C).
  • In COVID-19, E-ALT associated with obesity, immunocompromise, and higher C-reactive protein.
  • In MIS-C, E-ALT associated with male gender and Black race. Children with E-ALT in both groups had more severe disease, longer hospitalizations, and ICU stays. MIS-C carried a 2.3-fold increased risk of E-ALT compared to COVID-19.

Conclusions:

  • Elevated liver enzymes in SARS-CoV-2 infected children present as transaminitis without hepatic synthetic dysfunction.
  • Children with E-ALT, regardless of COVID-19 or MIS-C, experienced more severe clinical outcomes.
  • MIS-C demonstrated a higher prevalence of E-ALT compared to COVID-19 in pediatric patients.
Abstract

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.5K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
87
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.3K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
50
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.7K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
528